Hyperkinesis clinical trials
The registry lists 9 studies for Hyperkinesis across 4 countries. 2 are recruiting or about to start. 1 of them are mainly about Hyperkinesis (how this is decided). Per ClinicalTrials.gov, last updated 2026-03-19.
Get an email when these change. Save the Hyperkinesis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Centre Hospitalier de Saint-Denis (1) · Chiba University (1) · Virginia Polytechnic Institute and State University (1) · University Hospital, Limoges (1) · Pirogov Russian National Research Medical University (1) · Milton S. Hershey Medical Center (1) · Yaupon Therapeutics (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
What is being tested here
Drugs under test in Hyperkinesis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Oxymetazoline | 0 | 1 | 1 |
| Tipepidine | 0 | 0 | 1 |
| Lobeline | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. · Pirogov Russian National Research Medical University
- Apr 2027Parkinsonism-Related Oscillations in the Cortico-Basal Ganglia-Thalamic Network During Movement: Beyond the Frequency Range · University Hospital, Bordeaux
Who these studies take
Of the 2 Hyperkinesis studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 1 (50%) |
| 18 | 1 (50%) | 1 (50%) |
| 30 | 1 (50%) | 1 (50%) |
| 40 | 1 (50%) | 1 (50%) |
| 50 | 1 (50%) | 1 (50%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 9 studies, recruiting or not: 56% stop at 75 or younger and 44% at 65; 44% take children; 0% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. search them.
- Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders.RecruitingNCT07363603Phase 1/21 country
- Parkinsonism-Related Oscillations in the Cortico-Basal Ganglia-Thalamic Network During Movement: Beyond the Frequency RangeRecruitingNCT06438419Not applicable1 country
- Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic ShockCompletedNCT029182141 country
- Oxymetazoline Drops for Acquired Blepharoptosis From SynkinesisCompletedNCT05945615Phase 31 country
- Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental DelayCompletedNCT04816175Not applicable1 country
- Abnormal Hyperkinetic Movements Post Acute StrokeStatus unknownNCT053885521 country
- Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled TrialCompletedNCT02305134Phase 1/21 country
- Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult PatientsCompletedNCT00664703Phase 21 country
- Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement DisordersCompletedNCT000513371 country